Commonly Asked Questions about Addiction and Treatment
What does fentanyl do to a person?
Fentanyl is a synthetic opioid pain reliever that is 50 to 100 times more potent than morphine. It's typically used to treat severe pain, especially after surgery, or to manage pain in individuals with chronic illnesses who have developed a tolerance to other opioids.
When used under medical supervision, fentanyl can effectively relieve pain. However, when used illicitly or without a prescription, it can have severe, and even fatal, effects. Here's what fentanyl can do to a person:
Physical Effects: In the short term, fentanyl can induce feelings of relaxation, euphoria, and decreased perception of pain. However, it also slows breathing and can lead to unconsciousness or death from respiratory failure, particularly in high doses or when combined with other substances that depress the central nervous system.
Dependency and Addiction: Fentanyl is highly addictive. Regular use can lead to physical dependence, where the body requires the drug to function normally, and psychological addiction, where a person feels a compulsive need to use the drug despite its harmful consequences.
Overdose Risk: Due to its potency, the risk of overdose with fentanyl is high, especially if a person mistakenly believes they're taking a less potent opioid, as illicit fentanyl is often mixed with other drugs. Overdose can lead to severe respiratory depression, unconsciousness, and death.
Withdrawal: Once a person becomes dependent on fentanyl, stopping its use can result in withdrawal symptoms. These can include muscle and bone pain, sleep problems, diarrhea, vomiting, cold flashes, and uncontrollable leg movements.
Long-Term Health Effects: Chronic fentanyl use can lead to an array of health problems, including severe constipation, increased sensitivity to pain, confusion, depression, and increased risk of infections due to needle sharing (if injected).
Due to its potency and high risk of overdose, non-medical use of fentanyl is extremely dangerous. If you or someone you know is struggling with fentanyl or other opioid use, it's crucial to seek professional help immediately.
What are substance abuse factors for lgbtq+ individuals?
Substance abuse among LGBTQ+ (lesbian, gay, bisexual, transgender, queer, and others) individuals is influenced by a range of factors. These factors often intersect and can compound the risk for developing substance use disorders. Some of the primary factors include:
- Minority Stress: Minority stress refers to the additional stressors experienced by marginalized groups, such as LGBTQ+ individuals. This includes experiences of discrimination, stigma, harassment, and violence due to their sexual orientation or gender identity. This chronic stress can contribute to increased substance use as a coping mechanism.
- Mental Health: LGBTQ+ individuals are at a higher risk for certain mental health disorders, including depression, anxiety, and post-traumatic stress disorder. These mental health conditions can increase the risk of substance use and substance use disorders.
- Social Isolation and Rejection: The process of coming out to family and friends can sometimes result in rejection or loss of social support. This isolation and rejection can increase feelings of loneliness and despair, which may contribute to substance use.
- Internalized Homophobia or Transphobia: Internalized homophobia or transphobia refers to negative feelings, beliefs, and biases about one's own sexual orientation or gender identity. This internalized stigma can lead to lower self-esteem and increased risk of substance abuse.
- Lack of Access to Culturally Competent Healthcare: Many healthcare providers lack training in LGBTQ+ health issues, including substance use disorders, leading to barriers in access to effective, culturally competent treatment.
- Social Environments and Norms: Certain LGBTQ+ social settings, such as bars or clubs, often center around alcohol or other substance use, which may normalize and facilitate substance abuse.
- Trauma: LGBTQ+ individuals experience higher rates of certain types of trauma, such as physical or sexual abuse, hate crimes, or bullying, which can increase the risk of substance use disorders.
Are there racial inequities of the treatment of addictive disorders?
Yes, racial inequities do exist in the treatment of addictive disorders, reflecting systemic disparities that pervade many aspects of healthcare. These inequities can occur across multiple dimensions, including access to treatment, quality of care, and outcomes. Here are some ways in which these inequities manifest:
- Access to treatment: Racial and ethnic minority groups often face barriers to accessing substance use disorder treatment. These barriers can include factors like limited availability of treatment services in certain communities, lack of insurance or underinsurance, economic challenges, and lack of transportation.
- Quality of care: Even when individuals from racial and ethnic minority groups do access treatment, they may not receive the same quality of care as their white counterparts. This could be due to factors such as a lack of culturally competent care, bias or discrimination within the healthcare system, or treatment approaches that do not adequately consider cultural or community-specific factors.
- Treatment outcomes: Racial and ethnic disparities also exist in treatment outcomes for substance use disorders. For example, research has shown that African American and Hispanic individuals often have lower rates of successful completion of substance use disorder treatment programs compared to white individuals.
- Criminal justice involvement: There is a disproportionately higher rate of criminal justice involvement for substance use issues among people of color, particularly among African American and Hispanic populations. This can impact access to quality treatment, as well as long-term outcomes such as employment and social reintegration.
- Research gaps: Historically, much of the research on substance use disorders has primarily involved white participants, leading to a lack of data and understanding about the unique experiences, needs, and treatment responses of individuals from diverse racial and ethnic backgrounds.